Lifestyle
- Regular moderate exercise
- Avoid excessive alcohol consumption
Aspartat-Aminotransferase · ASAT · GOT · SGOT
AST quantifies the enzyme activity of aspartate aminotransferase in the blood, reflecting liver and muscle cell integrity.
Reference ranges may vary slightly based on age and sex. Consistent testing conditions are recommended.
Aspartate aminotransferase (AST), also known as glutamate oxaloacetate transaminase (GOT), is an enzyme that plays a critical role in amino acid metabolism. It catalyzes the reversible transfer of an amino group from aspartate to alpha-ketoglutarate, producing oxaloacetate and glutamate. This enzyme is found in various tissues, with high concentrations in the liver, heart, and skeletal muscles. Clinically, AST is an important biomarker for liver health. Elevated levels of AST are often indicative of liver damage or inflammation, as seen in conditions such as hepatitis, cirrhosis, and liver fibrosis. It can also be elevated in myocardial infarction and muscle disorders. For athletes and biohackers, monitoring AST can provide insights into muscle health and recovery, as intense exercise can temporarily increase AST levels. However, chronic elevation may suggest overtraining or underlying health issues. When interpreting AST levels, researchers observed that factors such as recent physical activity, alcohol consumption, and certain medications can influence results. Therefore, it is crucial to consider these confounders and ensure consistent testing conditions, such as fasting and time of day, to obtain reliable measurements.
Klinische Bedeutung
Elevated AST levels typically indicate liver damage or muscle injury. Low AST levels are generally not clinically significant but may occur in vitamin B6 deficiency.
Progressively rising AST values suggest worsening liver or muscle damage. Re-test in 4 weeks if outside optimal range.
Falling AST values may indicate recovery from liver or muscle injury.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant lifestyle or dietary changes, especially if AST levels are abnormal.
Testing Frequency
Annually for healthy adults, more frequently if monitoring liver health.
Current research suggests that reference ranges for ASAT (GOT) may vary significantly across different populations and methodologies, leading to inconsistencies in clinical interpretation. Researchers have not yet established optimal targets for ASAT in specific liver diseases, particularly in chronic hepatitis B and GM1 gangliosidosis. Additionally, clinical questions remain unanswered regarding the influence of confounding factors, such as co-morbidities and concurrent medications, on ASAT levels and their diagnostic utility.
275
Total Citations
14
Human/RCT
1.8
Avg. Influence
2025
Latest
Researchers discussed the variability of serum enzyme levels in diagnosing alcohol-related organ damage. They found that while elevated ASAT levels indicate potential liver injury, no single enzyme marker reliably distinguishes between alcohol-related and nonalcohol-related damage. The study emphasizes the need for test combinations to improve diagnostic accuracy.
Researchers investigated the effects of ursodeoxycholic acid (UDCA) on liver function in patients with hepatic sarcoidosis. They found that ASAT levels improved significantly in patients treated with UDCA compared to those receiving no treatment or corticosteroids. The study supports the potential use of UDCA in symptomatic patients with liver involvement.
This study assessed the incidence of hypoxic hepatitis in patients with cardiogenic shock. Researchers found that elevated ASAT levels were a strong predictor of 30-day mortality, with patients experiencing hypoxic hepatitis having significantly higher mortality rates. ASAT was identified as the most reliable laboratory predictor of outcomes in this patient population.
Researchers evaluated clinical and biochemical data from patients with GM1 gangliosidosis. They found that increased ASAT levels were present in a majority of patients, indicating potential utility in screening for the disease. The study emphasizes the importance of considering GM1 gangliosidosis in patients with progressive neurodegeneration.
Researchers reviewed methodologies for measuring aspartate aminotransferase (ASAT) and proposed a unifying reference system to improve interlaboratory compatibility. They emphasized the need for standardized enzyme reference materials and suggested the International Clinical Enzyme Scale to harmonize ASAT results across different laboratories. This approach aims to enhance the reliability of ASAT measurements.
Researchers analyzed clinical manifestations and laboratory findings in elderly patients with leptospirosis. They found that elevated ASAT levels were indicative of hepatic dysfunction, and the disease was associated with a severe course and higher mortality risk. Prompt intensive treatment is crucial for managing leptospirosis in elderly patients.
Researchers proposed a protocol for an enhanced cardiac enzyme profile to improve the diagnosis of myocardial injury. They highlighted the utility of ASAT and the ASAT/ALAT ratio in assessing myocardial damage, particularly when initial enzyme levels decline. This protocol aims to streamline diagnostic processes in clinical settings.
Researchers compared self-reported alcohol consumption questionnaires with laboratory markers for alcohol dependence. They found that ASAT levels, along with other markers, had low sensitivity for diagnosing alcoholism, although they showed high specificity. This study suggests that while alcohol markers can support diagnosis, they may not be reliable screening tools in general hospitals.
Researchers assessed the stability of capillary blood samples for various analytes, including ASAT, stored in Microtainers. They found that ASAT results from capillary samples showed acceptable agreement with serum samples, suggesting that capillary blood could be a viable alternative for health screenings.
Hamelink Tim L, et al. · Transplantation · 2025
Researchers compared biomarker release during hypothermic and normothermic machine perfusion in renal transplantation. They found moderate to strong correlations in ASAT levels between the two techniques, suggesting that both methods can provide valuable insights into kidney viability. However, the predictive value of these biomarkers remains uncertain.
Key findings
Research publications about AST (GOT) over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer